Searchable abstracts of presentations at key conferences in endocrinology

ea0019p323 | Steroids | SFEBES2009

Long-term consequences of auto-immune primary adrenal failure

Breen L , Thomas S , Doherty E , Powrie J , Brackenridge A , Carroll P

Background: Auto-immune Addison’s disease (AAD) is the most prevalent cause of primary adrenal insufficiency in the UK. Co-morbidities are commonly associated with AAD and can manifest years after the initial diagnosis. There is no clear consensus on the optimal surveillance and management of this condition.Objectives: To establish the prevalence of co-morbidities, assess bone health and review clinical surveillance practice of patients attending an...

ea0019p299 | Reproduction | SFEBES2009

Fertility in adults with congenital adrenal hyperplasia: congenital adrenal hyperplasia adult study executive (CaHASE)

Doherty E , Willis D , Wilid S , Breen L , Ross R , Carroll P , Adult Study Executive CaHASE CAH

CaHASE is a multicentre cross-sectional study of the health status of adults with congenital adrenal hyperplasia (CAH). Although fertility is considered to be reduced in both sexes, few published series report the proportion that has actively sought pregnancy. About 203 patients were recruited from 17 centres. Four patients (3, 11-hydroxylase, 1 HSD3B2 deficient) were excluded from analysis. Demographics are shown in Table 1.<table boarder="1" cellpadding="3" cellspacing="...

ea0021cm3.3 | Management of congenital adrenal hyperplasia across the lifespan | SFEBES2009

The adult with CAH: results of the UK congenital adrenal hyperplasia, adult study executive (CaHASE)

Ross R J , Willis D S , Wild S H , Krone N , Doherty E J , Han T S , Carroll P V , Conway G S , Rees D A , Stimson R H , Walker B R , Connell J C , Arlt W

Background: No treatment guidelines exist for CAH adults. To address this we have undertaken a cross-sectional analysis of health status.Patients and methods: Three hundred and eighty patients from 17 tertiary centres were contacted: 203 (53%) consented (138 f, 65 m, median age 34 (range 18–69) years). One hundred and sixty-five had classic and 34 non-classic CAH. The UK prevalence is 3591 adults >18 years therefore the capture rate was 5.7%. Re...